Introduction
============

In 2011, The National Clinical Database (NCD) was founded and registration of surgical cases was started in 2011. Based on the cases registered by the NCD, the Japanese Society for Vascular Surgery (JSVS) has summarized the data pertaining to vascular surgery and has published the respective results in the form of annual reports. In this report, we describe the results obtained following the summary and analysis of vascular surgery cases registered in the NCD between January and December 2012. The summary and analysis were performed by members of the JSVS Database Management Committee.

Methods
=======

Data pertaining to vascular surgery were extracted by NCD vascular surgery data analysis team under the request of JSVS. Results were summarized, checked, and analyzed by the members of JSVS Database Management Committee. NCD-registered treatments performed during 2012 were categorized into the following seven categories: 1) treatment for aneurysms, 2) revascularization for chronic arterial occlusion, 3) revascularization for acute arterial occlusion, 4) treatment for vascular trauma, 5) treatment for vascular complications after revascularization, 6) venous surgery, and 7) other vascular disease and related surgery. The cases in each category were summarized in consideration of the treatment procedures, causal factors, number of operative mortality, number of in-hospital mortality, and used materials. An operative mortality was defined as death occurring within 30 days of surgery, regardless of its cause or hospitalization status, whereas in-hospital mortality was defined as death occurring postoperatively during the same hospital stay, regardless of its length and timing.

Discrepancies were often observed in the numerical values presented in tables. For example, the sum of causal factors or used materials did not add up to the total number of cases. A thorough investigation performed by JSVS database committee and the NCD vascular surgery data analysis team revealed that the discrepancies resulted due to the following four reasons: 1) allowing multiple choice, 2) allowing blank spaces, 3) data entry error or exclusion by an administrator, and 4) a single surgery involving multiple materials or surgery being performed at multiple sites. Since 2013, various measures have been implemented to manage this issue, such as changing or redesigning the layout of choices or possible selections to prevent data entry errors and changing programming, wherever possible, to avoid blank results.

The categories/attributes for which the registration or summary method has been changed since 2012 are presented in [**Table 1**](#table1){ref-type="table"}.

###### Table 1 New items or changes in 2012 annual report

  New items                          Table number                                   Status until 2011
  ---------------------------------- ---------------------------------------------- -------------------
  Coil embolism                      [**Table 2-3**](#table2-3){ref-type="table"}   Not existed
  Laser ablation (± sclerotherapy)   [**Table 7-1**](#table7){ref-type="table"}     Not existed
  Valve plasty                       [**Table 7-1**](#table7){ref-type="table"}     Not existed
  Percutaneous shunting\*            [**Table 7-5**](#table7-5){ref-type="table"}   Not existed
  Modified items                                                                    
  Surgical recanalization            [**Table 7-5**](#table7-5){ref-type="table"}   "Decompression"

\*Percutaneous transjugular intrahepatic portosystemic shunt

Results
=======

In total, 95,979 cases (representing a 34.6% increase in relation to the previous year) of vascular treatments were registered in the NCD in 2012, accounting for 7.5% of all surgical cases registered that year.^[@R1])^ Further, 1,043 institutions (representing a 16% increase in relation to the previous year) were registered for performing vascular treatment, corresponding to 30.6% of the institutions registered for all types of surgery. Among the 1,043 institutions, 447 (42.9%) were cardiovascular surgery training-certified facilities that contributed to data registration in 2012. The summarized and analytical results of 2012 for each category will be discussed below. Statistical analysis was performed using Chi-squared test, and a level of p\<0.05 was considered statistically significant.

1. Treatment of Aneurysms (Table 2)
===================================

1) Thoracic aortic aneurysms
----------------------------

Most surgeries for thoracic aortic aneurysms are registered in the Japan Cardiovascular Surgery Database (JCVSD), which is managed by the JCVSD Organization. Among these, the surgeries performed by vascular surgeons are summarized in this vascular surgery database through the NCD ([**Table 2**](#table2){ref-type="table"}). Currently, the registration of the surgeries for thoracic aortic aneurysm performed in Japan is fragmented, complicating an accurate understanding of the overall view. A joint effort of the data registered in NCD and data registered in JCVSD will be needed to clarify the nationwide representation of thoracic aortic aneurysm surgery.

###### Table 2 Treatment for aneurysm Table 2-1 Aortic aneurysm

  Region of aortic aneurysm            Cases    Gender   Mortality   Ruptured aneurysm   Etiology                                                                       
  ------------------------------------ -------- -------- ----------- ------------------- ---------- ------- ----- ----- ----- -------- ----- ----- ----- --- ----- ---- -----
  Ascending aorta\*^1)^                343      168      175         46                  50         43      13    15    223   293      40    42    1     0   1     18   30
  Aortic arch\*^1)^                    610      466      144         46                  58         46      14    15    174   536      42    53    3     0   9     27   35
  Descending thoracic aorta\*^1)^      641      464      177         27                  34         77      8     11    198   556      34    30    2     1   22    22   37
  Thoracoabdominal aorta\*^1)^         385      283      102         38                  46         60      17    19    94    326      34    40    5     1   15    10   27
  Abdominal aortic aneurysm\*^2)^      15,745   13,073   2,671       420                 531        1,704   303   357   592   14,897   378   472   296   7   248   36   259
    with renal artery reconstruction   303      266      37          16                  19         45      10    11    28    276      15    18    7     1   6     4    9
    with renal artery clamping         1,175    995      180         75                  84         234     57    62    66    1,087    66    76    36    1   25    4    22

＊1) These data are not including cases recorded in JCVSD Database in which most cardiac surgeons were entering their cases. ＊2) Including common iliac artery aneurysm. ＊3) Including both acute and chronic aortic dissection. ＊4) Most likely atherosclerotic. ＊5) Connective tissue abnormalities such as Marfan syndrome.

###### Table 2-1 Aortic aneurysm (continued)

  Region of aortic aneurysm          Treatment procedures   Graft materials\*^7)^                                           
  ---------------------------------- ---------------------- ----------------------- ------- ---- ------- ---- ------- ----- ----
  Ascending aorta                    5                                                      0    12      6    304     14    2
  Aortic arch                        8                                                      6    261     99   281     55    2
  Descending thoracic aorta          13                                                     4    531     35   95      15    1
  Thoracoabdominal aorta             32                                                     11   174     41   167     27    7
  Abdominal aortic aneurysm          8,215                  6,229                   1,166   85   7,495   46   7,350   361   67
  with renal artery reconstruction   286                    220                     41      2    6       5    279     24    2
  with renal artery clamping         1,156                  893                     204     8    7       4    1,106   55    8

＊6) Debranch bypass surgery combined with two staged TEVAR is counted as one case of hybrid treatment. ＊7) Only for open surgery.

###### Table 2-2 Abdominal aortic aneurysm mortality classified by treatment procedures

  Procedure for aneurysm repair   Ruptured aneurysm   Non-ruptured aneurysm                      
  ------------------------------- ------------------- ----------------------- ----- ------- ---- -----
  Replacement                     1,353               261                     304   6,862   74   117
  Exclusion with bypass           27                  7                       8     58      2    5
  EVAR\*^8)^                      345                 41                      51    7,149   40   54
  Hybrid                          4                   0                       1     42      0    2

＊8) EVAR: endovascular aneurysm repair

###### Table 2-3 Peripheral artery aneurysm

  Aneurysm                      Cases   Gender   Mortality   Ruptured aneurysm   Etiology   Treatment procedures   Graft material for open surgery                                                                                             
  ----------------------------- ------- -------- ----------- ------------------- ---------- ---------------------- --------------------------------- ---- ------- ---- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ---
  Aortic arch branches                                                                                                                                                                                                                         
    Carotid                     18      10       8           0                   0          3                      0                                 0    9       3    1     1     3     4     2     7     2     2     6     3     2     1     0
    Verterbral                  0       0        0           0                   0          0                      0                                 0    0       0    0     0     0     0     0     0     0     0     0     0     0     0     0
    Subclavian                  53      32       20          2                   1          9                      1                                 0    34      0    3     3     13    18    7     7     16    7     6     10    11    3     0
    Multiple in arch branches   0       0        0           0                   0          0                      0                                 0    0       0    0     0     0     0     0     0     0     0     0     0     0     0     0
    Others                      10      7        3           0                   0          4                      0                                 0    4       0    0     2     4     2     1     2     1     4     1     3     0     0     0
  Upper limb artery                                                                                                                                                                                                                            
    Axillar                     22      15       7           1                   1          7                      1                                 1    15      1    0     2     4     14    4     5     0     1     1     1     8     9     0
    Brachial                    237     123      113         2                   7          53                     1                                 2    44      2    23    64    104   43    5     124   1     0     68    4     19    23    1
    Forearm---hand              148     94       54          3                   5          19                     1                                 1    48      1    27    27    45    11    3     114   0     0     23    2     2     5     1
    Others                      58      37       21          0                   0          19                     0                                 0    12      1    14    7     24    5     5     38    0     0     11    1     5     4     0
  Visceral artery                                                                                                                                                                                                                              
    Celiac                      25      21       4           1                   1          4                      1                                 1    23      0    0     0     2     6     4     2     2     10    2     4     2     3     0
    Hepatic                     12      10       2           1                   2          3                      1                                 2    6       1    1     1     2     2     2     2     0     7     0     0     0     3     0
    Splenic                     56      23       33          0                   1          3                      0                                 0    51      1    1     0     3     1     0     15    0     38    3     0     0     1     0
    Superior mesenteric         27      20       7           0                   0          4                      0                                 0    20      1    4     0     2     8     2     7     2     8     2     4     3     3     0
    Renal                       44      20       24          0                   0          1                      0                                 0    43      0    0     0     1     11    4     15    2     8     7     3     1     7     0
    Others                      405     328      77          6                   9          42                     3                                 5    365     1    13    2     24    104   12    50    135   160   7     96    16    4     0
  Lower limb artery                                                                                                                                                                                                                            
    Femoral                     487     362      125         14                  25         122                    10                                16   215     2    69    61    140   181   24    165   13    7     119   81    94    26    2
    Popliteal                   184     141      43          1                   2          23                     0                                 1    162     0    4     9     9     97    70    23    4     0     3     21    46    99    0
    Others                      111     85       26          5                   4          15                     2                                 2    75      1    9     3     23    18    6     35    28    28    12    9     4     7     1
  Total                         1,876   1,311    563         36                  58         332                    21                                31   1,109   15   169   182   399   514   145   610   203   278   267   230   210   197   5

＊9) Including TAO, Takayasu aortitis, collagen disease related vasculitis, Behçet disease, fibromuscular dysplasia. Abbreviations; Y-graft: Y-shape artificial graft, T-graft: straight shape artificial graft, Polyester: polyester artificial graft such as Dacron graft, ePTFE: expanded polytetrafluoroethylene graft

2) Abdominal aortic aneurysm (Tables 2-1 and 2-2)
-------------------------------------------------

A total of 15,745 cases of abdominal aortic aneurysm(AAA) (including common iliac artery aneurysm) were registered in the NCD in 2012, representing an increase of 2,527 cases in relation to the previous year.^[@R1])^ The number of replacement surgery including those using bifurcated synthetic or straight-type synthetic grafts increased by 1,135 cases, accounting for 52.2% of the total number of cases. Furthermore, the number of endovascular aneurysm repair (EVAR) using stent grafts increased by 1,622 cases, accounting for 47.6% of the total number of cases. Conversely, aneurysm exclusion with bypass and hybrid surgery decreased by one-half.

Of 8,250 cases of AAA surgery, excluding EVAR cases, 1,175 required renal artery clamping and 303 required renal artery reconstruction, representing 3.7% of open repair cases (1.9% of total AAA cases). Considering the increasing popularity of stent grafts, it was expected that percentage of pararenal AAA treated with open surgical repair was increasing; however, the increase was limited. In-hospital death rate in ruptured AAA cases with renal artery reconstruction was 24.4%, whereas those in ruptured AAA with renal artery clamping represented 26.5% of cases; these numbers remain nearly unchanged since 2011. In-hospital deaths following elective surgery with renal artery reconstruction, excluding rupture cases, represented 3.1% of cases, whereas in-hospital deaths following renal artery clamping accounted for 2.3% of cases. Remarkably, these values improved since 2011.

The number of treatments performed for rupture was 1,704, which represented an increase of 451 cases compared with that in 2011. The operative mortality rate within 30 days was 17.8%, whereas the in-hospital mortality rate was 21.0%; both decreased by approximately 1% compared with the rates observed in 2011. On the other hand, the operative mortality rate following elective surgery, excluding rupture cases, was 0.8%, whereas the in-hospital mortality rate was 1.2%; both remain nearly unchanged since 2011. Further, the operative mortality rate of patients on maintenance dialysis was 4.8% and in-hospital death rate was 7.1%, indicating that both deteriorated since 2011.

A stratified analysis was performed on the early outcomes of replacement surgery and EVAR for cases with and without rupture ([**Table 2-2**](#table2-2){ref-type="table"}). The operative mortality rate of replacement surgery for non-rupture cases was 1.1% and in-hospital mortality rate was 1.7%, whereas the rates for EVAR using stent grafting were 0.6% and 0.8%, respectively. Therefore, EVAR displayed significantly better outcomes than replacement surgery (p\<0.001) in terms of operative and in-hospital mortality rates. On the other hand, the operative mortality rate for replacement surgery in rupture cases was 19.3% and in-hospital mortality rate was 22.5%, whereas the rates for EVAR were 11.9% and 14.8%, respectively. Similarly, EVAR exhibited significantly better outcomes than replacement surgery (p\<0.001) in terms of operative and in-hospital mortality rates ([**Fig. 1**](#figure1){ref-type="fig"}). Reflecting these clinical experiences, EVAR was possibly selected in 20% of rupture cases (representing a 6% increase in relation to the previous year), showing an increasing trend of selection of EVAR as a treatment choice for ruptured AAA cases ([**Fig. 2**](#figure2){ref-type="fig"}). Caution is needed when we directly compare operative mortality rates of open repair with those of EVAR, because EVAR may be more frequently selected for patients considered anatomically or hemodynamically favorable.

![Fig. 1 Early clinical results of abdominal aortic aneurysm (AAA) in year 2012 comparing with those in year 2011. The operative mortality rate of non-ruptured AAA ([**Fig. 1A**](#figure1){ref-type="fig"}) and the ruptured AAA ([**Fig. 1B**](#figure1){ref-type="fig"}). Regarding the statistical difference of mortality rates between open repair (replacement) and EVAR, see main text.](avd-12-2-ar.19-00030-figure01){#figure1}

![Fig. 2 Treatment procedure for non-ruptured and ruptured abdominal aortic aneurysm (AAA). Comparing year 2011, proportion of EVAR selection increased especially in rupture cases of AAA.](avd-12-2-ar.19-00030-figure02){#figure2}

3) Peripheral arterial aneurysm (Table 2-3)
-------------------------------------------

In total, 1,876 cases of peripheral arterial aneurysm were registered. The male to female ratio was 1,311 : 563, indicating a higher incidence in men. Further, the number of incidences based on body parts were as follows: 782 cases, lower limb arteries; 569 cases, abdominal visceral artery aneurysms; 465 cases, upper limb arteries; and 81 cases, branches of aortic arch. Regarding incidences in different arteries, femoral artery aneurysms were most frequently observed (26.0%), followed by "others." We attempted to investigate the reason for this large proportion of "others" and found that a majority of "others" included internal iliac artery aneurysms. Considering this observation, the registration method of internal iliac artery aneurysms was directed toward amendment. In total, 332 cases were rupture cases (17.7%), which frequently occurred in the thigh or upper limbs, and this trend was similar to that reported in 2011. Treatment procedures were distributed as follows: ligation/resection (35.5%), replacement (27.4%), coil embolization (14.8%), and stent grafting (10.8%). The proportion of stent grafts has increased since 2011.

2. Revascularization for Chronic Arterial Occlusion (Table 3)
=============================================================

1) Aortic arch branch/upper limb/abdominal visceral artery
----------------------------------------------------------

No major changes have occurred in the number of cases of the carotid artery, vertebral artery, subclavian artery, and multiple aortic arch lesions compared with the number observed in 2011. However, the number of cases has increased for other arteries including the axillary to upper limb artery, celiac artery/superior mesenteric artery, and renal artery. Further, no significant differences were observed in terms of sex, disease causes, or surgical procedures.

###### Table 3 Revascularization for chronic arterial occlusive diseases\*^10)^ Table 3-1 Arterial reconstruction for aortic branches

  Aortic branches                       Cases   Gender   Mortality   Backgrounds   Etiology   Revascularization procedures   Graft materials\*^15)^                                                                                       
  ------------------------------------- ------- -------- ----------- ------------- ---------- ------------------------------ ------------------------ --- ---- --- ----- ---- --- ---- --- ----- ---- ---- ---- ---- ----- ---- ---- ---- ----
  Carotid artery                        116     97       19          3             9          4                              95                       0   0    2   19    16   0   79   4   1     3    7    7    3    6     7    6    3    2
  Vertebral artery                      0       0        0           0             0          0                              0                        0   0    0   0     0    0   0    0   0     0    0    0    0    0     0    0    0    0
  Subclavian artery                     117     85       32          1             16         12                             83                       0   3    1   30                      42    0    13   13   37   18    21   40   0    6
  Multiple lesions of arch branches     21      16       5           0             2          2                              16                       0   0    0   5     0    0   0    0   0     0    5    0    2    14    3    1    2    3
  Upper limb including axillar artery   107     71       36          0             40         19                             73                       2   4    0   27                      38    1    18   1    23   28    12   10   17   5
  Celiac/superior mesenteric artery     122     90       32          0             19         7                              98                       0   2    0   22                      67    11   19   0    2    23    18   6    7    1
  Renal artery                          167     131      36          0             5          9                              134                      0   3    2   27                      147   4    7    0    1    8     6    2    2    1
  Others                                73      56       17          0             8          5                              45                       0   4    0   24    0    0   0    0   27    3    13   8    12   21    13   15   3    13
  Total                                 711     540      171         4             98         57                             534                      2   16   5   152   16   0   80   4   322   21   77   28   77   115   78   74   34   30

###### Table 3-2 Arterial reconstruction for chronic lower limb ischemia

  From aorta to lower limb arterial system              Cases   Gender   Mortality   Backgrounds   Etiology   Graft materials\*^15)^                                                      
  ----------------------------------------------------- ------- -------- ----------- ------------- ---------- ------------------------ ------- ---- ---- --- ---- ------- ------- ------- -----
  Aorto--aorto bypass                                   62      44       18          0             7          5                        56      1    1    1   3    41      21      3       0
  Infrarenal aortic reconstruction (suprarenal clamp)   36      24       12          0             1          1                        32      0    0    0   4    34      3       1       0
  Aorto--femoral bypass\*^16)^                          739     608      131         8             49         64                       708     5    1    3   19   569     198     30      6
  Femoro--popliteal (above knee) bypass                 2,139   1,615    524         35            254        257                      2,117   3    1    2   11   386     1,538   334     27
  Infragenicular arterial bypass                        1,874   1,381    493         33            548        368                      1,796   19   8    3   27   126     411     1,376   92
    Femoro--popliteal (below the knee) bypass           729     532      197         13            144        130                      707     2    0    1   8    81      274     405     32
    Femoro--crural/pedal bypass\*^17)^                  1,173   870      303         20            411        241                      1,117   17   8    2   19   46      147     998     61
  Others                                                194     143      51          2             22         32                       179     0    1    1   13   71      86      38      4
  Total                                                 4,800   3,625    1,175       72            853        697                      4,649   26   12   8   76   1,100   2,113   1,682   124

###### Table 3-3 Extra-anatomic bypass\*^18)^

  Extra-anatomical bypass             Cases   Gender   Mortality   Backgrounds   Etiology   Graft materials\*^15)^                                         
  ----------------------------------- ------- -------- ----------- ------------- ---------- ------------------------ ------- --- ----- ----- ------- ----- ----
  Carotid--subclavian bypass          28      22       6           0             3          2                        13      0   15    14    12      2     1
  Axillo--axillar bypass              77      64       13          1             7          5                        45      0   31    23    46      3     21
  Axillo--femoral bypass\*^19)^       427     299      128         16            59         57                       389     5   31    168   264     23    5
  Femoro--femoral cross-over bypass   1,004   810      194         13            74         100                      982     2   19    283   685     56    18
  Others                              159     103      56          4             33         36                       142     1   14    46    69      22    2
  Total                               1,653   1,269    384         32            172        195                      1,534   8   105   523   1,044   104   46

###### Table 3-4 Thromboendarterectomy\*^20)^ for chronic lower limb ischemia

  Thromboendarterectomy      Cases   Gender   Mortality   Dialysis cases   Etiology             
  -------------------------- ------- -------- ----------- ---------------- ---------- ----- --- ----
  Aorto--iliac lesion        59      46       13          2                15         54    0   2
  Femoro--popliteal lesion   851     631      220         7                198        834   2   5
  Others                     108     81       27          1                25         101   0   5
  Total                      1,008   751      257         10               236        983   2   12

###### Table 3-5 Endovascular treatment for chronic lower limb ischemia\*^14)^

  Endovascular treatment                           Cases   Gender   Mortality   Dialysis cases   Etiology                        
  ------------------------------------------------ ------- -------- ----------- ---------------- ---------- ------- ------- ---- ----
  Aorto--iliac lesion\*^21)^                       2,922   1,399    523         31               41         357     1,884   3    35
  Femoro--popliteal lesion\*^21)^                  2,436   1,706    730         23               44         650     2,421   4    11
  Infrapopliteal--ankle lesion\*^21)^              1,277   848      428         19               47         584     1,262   7    8
  Others                                           57      39       18          0                0          20      50      1    6
  Total (number of regions underwent EVT)\*^21)^   5,792   4,336    1,455       59               106        1,318   5,727   12   53
  Total (number of limbs underwent EVT)\*^22)^     4,944   3,719    1,224       46               83         1,046   4,889   9    46

＊10) Bypass surgery combined with endovascular treatment is counted in both bypass category ([**Table 3-2**](#table3-2){ref-type="table"}) and endovascular category ([**Table 3-5**](#table3-5){ref-type="table"}). ＊11) Including redo operation only. Revision surgery cases should be counted in vascular complication part (see [**Table 6**](#table6){ref-type="table"}). ＊12) Including collagen disease related vasculitis, Behçet disease, fibromuscular dysplasia. ＊13) Postoperative irreversible brain complication. ＊14) Including percutaneous transluminal angioplasty (PTA), stent, and other endovascular means such as catheter atherectomy. ＊15) Only for open surgery. ＊16) Including aorto--iliac bypass or ilio--femoral bypasses. ＊17) Including popliteal--crural (or pedal) bypass. ＊18) Cases underwent extraanatomic bypass because of graft infection should not be included in this category. Those cases are listed in vascular complication ([**Table 6**](#table6){ref-type="table"}). ＊19) A case underwent axillo--femoro--femoral crossover bypass is counted as on case. A case combined with additional contralateral side of axillilo--femoral bypass as second staged surgery is counted as 2 cases. ＊20) Including patch plasty. ＊21) When endovascular treatment performed for multiple region, the case should be counted in each region (If a case underwent endovascular treatment in both aorto--iliac and femoro--popliteal region, this case can be counted one in aorto--iliac, and one in femoro--popliteal region). ＊22) Counting the patients number. When a case underwent endovascular treatment in multiple regions, the case is counted as one case. Abbreviations; ASO: arteriosclerosis obriterance, TAO: thromboangiitis obliterans (Buerger's disease), CAS: carotid artery stenting, CEA: carotid endarterectomy, PTA: percutaneous transluminal angioplasty, EVT: endovascular treatment, IIA: internal iliac artery

The number of cases of the carotid artery has remained essentially constant, with 118 cases observed in 2011 and 116 cases in 2012. In 2011, 80% of cases underwent carotid endarterectomy (CEA) and 10% underwent carotid stenting (CAS). In 2012, 68% of cases underwent CEA and 14% of cases underwent CAS, representing a slight increase in the proportion of CAS. Anatomical bypass or carotid-to-subclavian artery bypass increased to seven cases in 2012, but the latter was believed to be performed during debranching surgery associated with thoracic endovascular aneurysm repair (TEVAR). The proportion of "others" increased by approximately 50% from 49 cases in 2011 to 73 cases in 2012, but most of these included carotid-to-subclavian artery bypass or axillo--axillary bypass performed as debranching surgery associated with TEVAR, and the increase was believed to be caused by the increase of TEVAR requiring debranching surgeries.

2) Anatomical bypass, extra-anatomical bypass, and endovascular treatment in the aorta to lower limb regions
------------------------------------------------------------------------------------------------------------

**Aorto-iliac region**: Anatomical revascularization surgery on lesions in the aorto-iliac region increased by approximately 7% from 782 cases in 2011 to 837 cases in 2012, but there was no change in the distribution of the types of vascular grafts used. The use of extra-anatomical revascularization surgery represented by axillo--femoral bypass and femoro--femoral bypass tended to increase slightly from 397/961 cases in 2011 to 427/1,004 cases in 2012. Endovascular treatment (EVT) also increased from 2,569 cases in 2011 to 2,922 cases in 2012, and the treatment in this region has shown a slight overall increase in Japan. Notably, the rate of increase was larger for EVT than for bypass surgery ([**Fig. 3**](#figure3){ref-type="fig"}), and EVT is now considered the first-line treatment for this region.^[@R1])^

![Fig. 3 The annual trends of the number arterial reconstructions in aortoiliac, femoro--popliteal, and crural/pedal region, comparing open repair and endovascular treatment. The broken line lying between year 2010 and 2011 indicates the timing of alteration of data collection methods. Data has been prospectively registered since January 2011, while the data had been retrospectively collected annually from 2004 until 2010.](avd-12-2-ar.19-00030-figure03){#figure3}

**Superficial femoral artery region**: The number of femoral above-knee popliteal artery bypass increased by 125 cases from 2,014 cases in 2011 to 2,139 cases in 2012; the incidence of EVT in this region increased by 602 cases from 1,834 cases in 2011 to 2,436 cases in 2012 ([**Fig. 3**](#figure3){ref-type="fig"}). EVT is being more commonly performed possibly because the treatment protocol is shifting from bypass surgery to EVT and because EVT is a less-invasive procedure. Conversely, no major changes were observed in the selection of vascular grafts.

**Revascularization below the knee joint**: Femoral below-knee popliteal artery bypass and femoro--crural/pedal artery bypass were performed on 658 and 984 cases in 2011, respectively, which increased by approximately 260 cases to 729 and 1,173 cases in 2012, respectively. Endovascular treatment increased by 316 cases from 961 cases in 2011 to 1,277 cases in 2012 ([**Fig. 3**](#figure3){ref-type="fig"}). Further, there was no substantial difference in terms of the proportion of dialysis patients, and the overall number was believed to have increased due to an increase in the incidence of critical limb ischemia with basal conditions of diabetes or dialysis.

**Thromboendarterectomy**: There were 50 and 568 cases of thromboendarterectomy performed in the iliac artery and femoro--popliteal regions in 2011, respectively, which increased to 59 and 851 cases in 2012, respectively, with a substantial increase in the femoro--popliteal region ([**Fig. 3**](#figure3){ref-type="fig"}). Common femoral artery lesions are observed in the femoro--popliteal region, so the use of endarterectomy in this region is believed to have increased.

3. Revascularization for Acute Arterial Occlusion (Table 4)
===========================================================

Percutaneous transluminal angioplasty (PTA) with or without stenting is a treatment procedure being more commonly performed, increasing from 8.5% of total cases in 2011 to 10.6% of those in 2012. This particularly includes an increase from 7.5% to 10.3% in the femoro--popliteal region, which is believed to reflect the popularization of EVT.

###### Table 4 Revascularization for acute arterial occlusive disease\*^23)^

  Obstructive artery\*^24)^           Cases   Gender   Mortality   Etiology   Procedure   Graft materials for open surgery                                                                  
  ----------------------------------- ------- -------- ----------- ---------- ----------- ---------------------------------- ------- ----- ------- ----- ---- ----- ----- ----- ----- ----- ----
  Carotid artery                      3       2        1           2          2           1                                  2       0     0       1     0    1     1     0     1     0     0
  Subclavian artery                   63      31       32          5          6           28                                 20      15    32      18    4    9     3     3     15    7     0
  Axillar artery                      66      24       42          4          5           37                                 25      4     52      8     0    5     3     3     2     7     0
  Brachial artery                     727     353      374         14         19          350                                355     22    597     16    9    35    94    17    12    20    3
  Celiac/superior mesenteric artery   108     70       38          12         17          50                                 30      28    53      31    2    8     16    21    6     7     0
  Renal artery                        17      10       7           2          2           5                                  2       10    2       3     0    6     6     1     2     0     0
  Abdominal aorta--iliac artery       723     501      222         76         99          260                                371     92    430     210   17   141   35    15    120   112   5
  Femoro--popliteal artery            2,433   1,571    862         191        244         1,019                              1,310   103   1,976   303   33   250   139   121   142   173   12
  Crural artery                       729     473      256         49         71          334                                374     20    590     74    4    97    59    52    21    30    6
  Pedal artery                        51      35       16          6          8           26                                 24      1     41      7     0    5     3     5     2     1     1
  Others                              314     205      109         14         21          46                                 222     46    203     60    4    40    34    43    15    21    4
  Total                               4,600   2,879    1,721       310        404         1,882                              2,401   316   3,472   635   65   489   349   246   288   339   29

＊23) Cases with non-traumatic acute arterial occlusion are listed in this table. Please see [**Table 5-1**](#table5){ref-type="table"} for acute arterial occlusion by trauma. ＊24) The most proximal occluded artery name is described in case whose primary occluded artery could not be identified. ＊25) Cases with acute worsening occlusion of chronic arterial occlusive disease are excluded. Treatment for those cases are listed in [**Table 3**](#table3){ref-type="table"}.

In cases of occlusion, multiple regions are selected if the obstructed region ranges across a wide area; hence, the total numbers do not add up. Changes in data entry methods did not occur in this region.

4. Treatment for Vascular Trauma (Table 5)
==========================================

The location of vascular injury, reasons for injury, categorization based on treatment procedure, and used vascular grafts for NCD-registered cases in 2012 are shown in [**Table 5**](#table5){ref-type="table"}. A total of 1,623 cases were registered, including cases of artery and vein traumas. The most common reason for vascular injury was iatrogenic conditions, with 978 such cases (60.3%). Traffic accidents comprised 134 cases (8.3%), and work-related cases included 130 cases (8.0%). Further, the most common location of vascular injury was lower limb arteries (45.3%), followed by upper limb arteries (19.9%) and abdominal aorto-iliac arteries (6.2%).

###### Table 5 Treatment for vascular trauma Table 5-1 Arterial trauma

  Injured artery                                 Cases   Gender   Mortality   Cause of trauma   Procedure   Graft materials                                                                           
  ---------------------------------------------- ------- -------- ----------- ----------------- ----------- ----------------- ----- ----- ----- ----- ---- ---- ----- ----- ----- ---- ---- ---- ---- ---
  Carotid artery                                 56      38       18          2                 5           0                 2     10    44    13    0    0    35    3     7     2    0    13   23   4
  Subclavian artery                              74      51       23          6                 6           4                 4     13    53    12    0    0    52    6     6     5    1    19   33   4
  Axillar artery                                 26      21       5           1                 1           5                 6     6     9     6     0    3    14    1     2     2    6    0    11   0
  Brachial artery                                223     150      73          3                 5           5                 22    169   27    157   3    6    18    3     34    10   21   0    6    0
  Descending aorta (thoracic/thoracoabdominal)   50      34       16          18                19          23                7     5     15    10    0    5    3     18    3     13   0    3    5    0
  Celiac/superior mesenteric artery              29      19       10          3                 4           8                 1     11    9     6     0    0    4     13    8     0    1    1    1    0
  Renal artery                                   10      6        4           1                 0           3                 1     5     1     2     0    0    0     7     0     1    0    0    0    0
  Abdominal aorta--iliac artery                  101     58       43          17                22          13                6     62    20    33    3    11   8     33    9     14   2    12   9    0
  Femoro--popliteal artery                       703     430      273         93                124         33                37    503   130   550   20   31   44    17    33    29   49   15   28   2
  Crural artery                                  32      23       9           0                 1           7                 5     13    7     5     0    2    16    2     5     2    13   1    3    0
  Others                                         227     141      86          21                30          22                27    105   73    85    3    4    7     16    103   24   8    3    1    2
  Total                                          1,476   934      542         161               211         118               117   897   344   876   27   61   155   115   203   99   99   53   87   8

###### Table 5-2 Venous trauma\*^26)^

  Injured vein                       Cases   Cause of trauma   Procedure   Graft materials                                                   
  ---------------------------------- ------- ----------------- ----------- ----------------- ---- ---- --- --- --- --- ---- ---- --- --- --- ---
  Superior vena cava                 3       0                 0           2                 1    2    0   0   0   0   1    0    0   0   0   0
  Inferior vena cava                 8       3                 1           2                 2    6    1   0   0   0   0    1    0   0   0   1
  Brachiocephalic--subclavian vein   14      0                 1           5                 8    5    0   0   0   3   3    4    0   0   0   0
  Iliac--femoral--popliteal vein     45      3                 4           31                7    34   2   1   1   0   7    3    2   1   1   0
  Others                             79      10                7           42                20   30   2   4   3   1   37   6    2   1   4   0
  Total                              147     16                13          81                37   75   5   5   4   4   47   14   4   2   5   1

＊26) Cases with vessel injury involving both vein and accompanying artery are listed in [**Table 5-1**](#table5){ref-type="table"}.

In total, 1,690 cases were registered for treatment procedures, while hemostasis and repair by direct suture comprised 58.6% of total cases. Additionally, only 259 cases received vascular grafts, but approximately 40% of all vascular grafts were autogenous grafts. Autogenous grafts appear to be selected for revascularization of peripheral vessels whenever possible because traumatic wounds are often infected.

1) Iatrogenic vascular trauma
-----------------------------

The most common type of iatrogenic vascular injury is considered the complications associated with catheter-involving operations. Other than injuries acquired during examinations or treatments for cardiovascular diseases, injury may occur during catheter embolization of visceral arteries for malignant tumors, intra-arterial chemotherapy, or intravenous feeding catheters. In addition, injury may result from accidental vascular injury during surgery.

Lower limb arteries were the most common site of iatrogenic vascular injury (approximately 55% cases), followed by upper limb arteries (approximately 20% of cases); most of these cases are believed to be complications of catheter puncture sites.

2) Traffic accidents
--------------------

A total of 134 cases of vascular injury caused by traffic accidents have been registered. However, it is unknown whether this small number of cases reflects the actual situation. The most frequent region of injury was lower limb arteries, comprising approximately 37% of cases; this is likely because the vessels of the lower limbs are close to the body surface and are prone to direct external force. The second most frequent injury site was the descending or thoracoabdominal aorta (17%), followed by upper limb arteries (10%) and abdominal aorto-iliac arteries (10%) ([**Fig. 4A**](#figure4){ref-type="fig"}). During traffic accident collisions, the mediastinum is dislocated due to sudden deceleration, focusing stress on the bifurcation area between the cervical/upper limb branches fixed to the thorax. This subsequently causes dissection or laceration/interruption of the descending thoracic aorta in the branching site of the left subclavian artery. The higher proportion of damage in the thoracic aorta than those of the other causes of vascular injury is possibly a result of the exclusivity of traffic accident-related traumas.

![Fig. 4 The location of vascular injury in year 2011 and 2012. Injured vessel injured by trafﬁc accident (**A**) and work-related accident (**B**).](avd-12-2-ar.19-00030-figure04){#figure4}

3) Work-related trauma
----------------------

Causes categorized as "work-related" in the NCD database are thought to include industrial accidents such as fall from high places or being caught in machinery. Of the 130 cases registered, approximately 60% occurred in the arteries of the extremities that are prone to external force owing to their proximity to the body surface, as mentioned previously ([**Fig. 4B**](#figure4){ref-type="fig"}).

4) Other vascular trauma
------------------------

Causes of vascular injury other than iatrogenic or traffic accidents include those caused by freak accidents and due to deliberate damage (or self-inflicted injury). Disease-related vascular wall damage, such as tumor invasion to blood vessels, is considered a type of vascular injury.

The most frequent injury sites are the vessels of the extremities, comprising 66% of cases. Injuries caused in the parts resistant to direct external force, such as the thoracic/abdominal aorta or carotid artery, are likely to include those resulting from direct invasion of malignant tumors or those caused by self-inflicted injury.

We summarized the registration status of vascular injuries in the NCD database of 2012. The total number of registered cases has increased since the 2011 report, but it is unclear whether the registered number of vascular injury caused by traffic accidents reflects the actual numbers.

Notably, there were no major differences in terms of causes of trauma, areas of trauma, or types of vascular grafts used. However, the number of cases involving repair using EVT substantially increased from 5.7% of total cases (61 cases) in 2011 to 7.3% (119 cases) in 2012. This likely occurred because of the popularization of coil embolization or stent graft indwelling for the bleeding area.

5. Treatment for Vascular Complications after Revascularization (Table 6)
=========================================================================

1) Artificial graft infection
-----------------------------

There were 48 in-hospital deaths out of 466 total cases (10.5%). In 2011, there were 76 in-hospital deaths out of 445 cases (17.1%), indicating this rate markedly decreased by 2012. Further, there were no major differences in terms of treatment procedures or types of vascular grafts used between 2012 and 2011.

###### Table 6 Revascularization for vascular complication after revascularization Table 6-1 Graft infection

  Position of infected graft        Cases   Mortality   Procedure for graft infection   Material for revision or redo surgery                                  
  --------------------------------- ------- ----------- ------------------------------- --------------------------------------- ---- ----- ---- ----- ---- --- ----
  Thoracic descending aorta         3       0           0                               2                                       0    1     0    1     0    1   0
  Thoracoabdominal aorta            4       0           0                               2                                       0    2     1    1     0    0   0
  Abdominal aorta--iliac artery     33      8           11                              7                                       17   9     15   9     2    0   1
  Abdominal aorta--femoral artery   48      2           6                               10                                      11   27    16   9     5    0   0
  Femoro--distal artery             137     5           14                              15                                      19   103   12   38    24   0   4
  Others\*^27)^                     241     10          18                              18                                      33   190   35   64    25   0   9
  Total                             466     25          49                              54                                      80   332   79   122   56   1   14

＊27) Cases with graft infection involving aortic arch branch or upper limb artery are listed on this column.

###### Table 6-2 Anastomotic aneurysm\*^28)^

  Location of anastomotic aneurysm             Cases   Mortality   Cause of aneurysm treated at the primary operation   Repair procedure   Material for repair surgery                                                
  -------------------------------------------- ------- ----------- ---------------------------------------------------- ------------------ ----------------------------- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---
  Aortic arch branch                           7       1           4                                                    0                  1                             0    2    1    2    3    2    4    2    1    0
  Upper limb artery including axillar artery   34      3           8                                                    0                  0                             7    19   3    1    0    30   2    5    1    0
  Thoracic aorta                               18      2           11                                                   0                  0                             1    6    1    0    13   6    9    6    0    0
  Splanchnic artery                            1       0           0                                                    0                  0                             0    1    0    0    1    0    1    0    0    0
  Renal artery                                 1       0           0                                                    0                  0                             0    1    0    0    0    1    0    0    0    0
  Abdominal aorta                              28      2           21                                                   0                  0                             3    4    6    1    17   7    19   4    0    2
  Iliac artery                                 22      0           12                                                   0                  0                             1    9    5    0    11   8    11   4    0    5
  Femoral artery                               59      3           24                                                   0                  0                             21   14   24   6    0    31   7    21   12   1
  Popliteal or more distal lower limb artery   10      0           3                                                    0                  0                             2    5    4    1    0    5    0    4    2    1
  Total                                        178     11          82                                                   0                  1                             35   60   44   11   44   88   52   46   16   9

＊28) Cases with infectious pseudoaneurysms located at the anastomotic site to the artificial graft are listed in [**Table 6-1**](#table6){ref-type="table"}. ＊29) Including the atherosclerotic aneurysm. ＊30) Including TAO, collagen disease, Behçet disease, and fibromuscular dysplasia.

###### Table 6-3 Autogenous graft aneurysm

  Revascularization area   Cases   Mortality   Repair procedure       
  ------------------------ ------- ----------- ------------------ --- ----
  Visceral artery          0       0           0                  0   0
  Upper limb artery        47      1           4                  3   39
  Lower limb artery        25      0           2                  4   19
  Others                   19      0           0                  2   17
  Total                    86      1           6                  9   73

###### Table 6-4 Graft degeneration

  Revascularization area            Cases   Mortality   Initial revascularization procedure   Degenerated material   Repair procedure   Material for repair surgery                                                  
  --------------------------------- ------- ----------- ------------------------------------- ---------------------- ------------------ ----------------------------- ---- ---- --- ---- ---- --- --- ---- ---- ---- ---
  Descending thoracic aorta         1       0           1                                     0                      0                  0                             1    0    0   0    0    0   1   0    1    0    0
  Thoracoabdominal aorta            0       0           0                                     0                      0                  0                             0    0    0   0    0    0   0   0    0    0    0
  Abdominal aorta--femoral artery   8       0           5                                     2                      0                  1                             5    3    0   2    1    2   1   3    6    0    0
  Femoro--popliteal artery          12      0           2                                     8                      0                  2                             1    11   0   2    5    0   1   4    1    6    1
  Others                            38      1           5                                     16                     0                  17                            9    23   6   11   4    2   1   20   7    13   4
  Total                             58      1           13                                    25                     0                  20                            16   36   6   15   10   4   4   26   15   19   5

###### Table 6-5 Repair operation for graft stenosis or acute thrombosis\*^31)^

  Initial procedure                                 Cases   Mortality   Repair procedure   Material for repair surgery                                       
  ------------------------------------------------- ------- ----------- ------------------ ----------------------------- ----- ----- ----- ----- ----- ----- ----
  Reconstruction of aorta or its primary branches   109     4           22                 6                             35    43    14    38    26    9     15
  Revascularization of upper limb                   475     6           101                16                            20    231   124   11    52    341   6
  Revascularization of lower limb                   604     17          287                59                            154   163   50    64    149   187   12
  Total                                             1,182   27          407                79                            207   437   188   112   226   534   33

＊31) Including stenosis such as the anastomotic stenosis, graft stenosis or occlusion, and restenosis at the site of endarterectomy.

2) Anastomotic aneurysms
------------------------

The category "rupture" was added in 2012. Of 178 anastomotic aneurysm cases, 50 ruptured and 7 patients died owing to operative mortality. The most frequent cause was arteriosclerosis, similar to that observed in 2011, followed by infection.

3) Autogenous graft aneurysms
-----------------------------

The number of cases, number of operative mortality, and treatment procedures remained constant compared to those observed the previous year.

4) Artificial graft deterioration
---------------------------------

Fifty-eight cases experienced artificial graft deterioration in 2012, which increased from 33 cases in 2011. The most frequent primary surgical procedure was bypass, followed by replacement. Moreover, there were no cases of stent graft deterioration in 2012, but reports may increase in the future due to the increase in the use of stent graft indwelling.

5) Repair operation for restenosis and acute occlusion of vascular grafts
-------------------------------------------------------------------------

Compared with 2011, upper limb arterial reconstruction increased by 2.2-fold and lower limb arterial reconstruction increased by 1.2-fold in 2012. Overall, arterial reconstruction increased by 1.5-fold to 1,182 cases in 2012. Regarding reconstruction procedures, PTA with and without stenting of the upper limb increased from 65 cases in 2011 to 231 cases in 2012 (3.6-fold increase). The use of autogenous grafts increased from 39 cases in 2011 to 341 cases in 2012 (i.e., an 8.7-fold increase).

6. Venous Surgery (Table 7)
===========================

1) Varicose veins (Table 7-1)
-----------------------------

A total of 30,086 cases were registered in 2012, representing a massive increase of approximately 60% compared with 2011. Stripping (with and without sclerotherapy) was performed in 16,163 cases (54%) and was the most common surgical procedure. However, 8,186 cases of endovenous laser ablation (EVLA) with and without sclerotherapy as a novel therapeutic method were registered and comprised approximately one-fourth of all varicose vein treatments. EVLA was covered by insurance for the first time in 2011, and the equipment for radiofrequency ablation, a 1,470-nm model for EVLA, and a radially emitting laser fiber were approved in 2014. EVLA was the most common treatment reported in the 2016 Japanese Society of Phlebology survey^[@R2])^ and is expected to increase in the future.

###### Table 7 Venous surgery Table 7-1 Varicose veins

  Varicose veins treatment         Cases\*^32)^   Male     Female   30-day mortality
  -------------------------------- -------------- -------- -------- ------------------
  High ligation ± sclerotherapy    4,651          1,540    3,111    0
  Stripping ± sclerotherapy        16,163         6,291    9,870    3
  Laser ablation ± sclerotherapy   8,186          2,504    5,682    0
  Valve plasty                     6              4        2        0
  Others                           1,082          322      760      0
  Total                            30,088         10,661   19,425   3

＊32) Only one procedure can be registered in one leg.

###### Table 7-2 Deep vein thrombosis (DVT)

  DVT treatment                           Cases   Male   Female   30-day mortality
  --------------------------------------- ------- ------ -------- ------------------
  Thrombectomy                            71      33     38       0
  Catheter-directed thrombolysis\*^33)^   40      23     17       0
  Bypass                                  9       3      6        0
  IVC filter insertion\*^34)^             327     152    175      3
  Total                                   395     181    214      3

＊33) Including the catheter-directed thrombolysis using hydrodynamic thrombectomy catheter. ＊34) Including temporary IVC filter.

###### Table 7-3 Upper limb vein obstruction

  Treatment of vein obstruction    Cases   Male   Female   30-day mortality
  -------------------------------- ------- ------ -------- ------------------
  Thrombectomy                     86      48     38       1
  Catheter-directed thrombolysis   19      14     5        0
  Bypass                           51      32     19       1
  SVC filter insertion             1       0      1        0
  Total                            152     92     60       2

###### Table 7-4 Vena cava reconstruction

  Vena cava reconstruction   Cases   Mortality   Etiology   Treatment procedures   Material for open surgery                                             
  -------------------------- ------- ----------- ---------- ---------------------- --------------------------- ---- ---- --- ---- --- ---- ---- --- ---- ----
  SVC reconstruction         18      1           1          6                      7                           5    2    2   2    3   9    1    1   3    8
  IVC reconstruction         63      6           7          49                     3                           11   15   3   11   0   34   10   2   13   4
  Total                      81      7           8          55                     10                          18   17   5   13   3   43   11   3   16   12

Abbreviations; IVC: inferior vena cava, SVC: superior vena cava

###### Table 7-5 Budd--Chiari syndrome

  Treatment                 Cases   Gender   Mortality   Material for open surgery                   
  ------------------------- ------- -------- ----------- --------------------------- --- --- --- --- ---
  Shunting                  3       1        2           0                           0   0   1   1   0
  Surgical recanalization   5       4        1           0                           0   0   0   3   1
  Percutaneous shunting     1       1        0           0                           0   0   0   0   0
  Total                     9       6        3           0                           0   0   1   4   1

2) Deep vein thrombosis (Table 7-2)
-----------------------------------

A total of 395 cases were registered and distributed as follows: 71 cases of thrombectomy (18%), 40 of catheter-directed thrombolysis (CDT) (10%), and 9 of bypass surgery (peripheral vein revascularization) (2%). Notably, no major changes were observed in 2012 compared with 2011. The most frequent treatment was filter insertion including temporary type in 327 cases (82%). CDT remained limited.

3) Upper limb vein obstruction (Table 7-3)
------------------------------------------

Compared with 2011, the number of treatments increased by 1.7-fold in 2012 to 152 surgeries. However, no changes were observed in the distribution of treatment procedures.

4) Vena cava reconstruction (Table 7-4)
---------------------------------------

A total of 81 cases were registered, which represented a slight increase from 2011. The cases were distributed as follows: 22%, superior vena cava/primary branch reconstructions and 78%, inferior vena cava/primary branch reconstructions. The most frequent cause was tumors (55 cases, 68%). Moreover, the outcomes showed deterioration compared with those of the previous year, with seven operative deaths (8.6%) and eight in-hospital deaths (9.9%). Surgical procedures involved patching in 17 cases, replacement in 13, and bypass in 5. Forty-two cases of vascular grafts were registered, with 16 cases of ePTFE being the most frequent type.

5) Budd--Chiari syndrome (Table 7-5)
------------------------------------

A total of nine treatments were performed. The treatment procedures were newly divided into shunt surgery, percutaneous shunt creation, and open repair; further, no PTA cases were registered. Percutaneous shunt creation is likely to represent transjugular intrahepatic portosystemic shunt.

7. Other Vascular Diseases and Related Surgery (Table 8)
========================================================

No major changes were observed in the number of registered cases for other vascular diseases and related surgeries between 2011 and 2012.

###### Table 8 Other vascular diseases Table 8-1 Popliteal artery entrapment syndrome

  Treatment           Cases   30-day mortality
  ------------------- ------- ------------------
  Myotomy             9       0
  Revascularization   45      1
  Total               49      1

###### Table 8-2 Adventitial cystic disease

  Treatment                      Cases   30-day mortality
  ------------------------------ ------- ------------------
  Cyst excision ± patch plasty   43      1
  Replacement                    18      1
  Bypass                         4       0
  Total                          63      2

###### Table 8-3 Throracic outlet syndrome (TOS)

  Treatment                      Cases   Male   Female   30-day mortality   Type of TOS\*^35)^       
  ------------------------------ ------- ------ -------- ------------------ -------------------- --- ---
  Rib resection\*^36)^           3       2      1        0                  1                    0   3
  Rib resection + scalenectomy   3       2      1        0                  2                    1   0
  Bypass                         5       4      1        0                  1                    0   5
  Total                          10      7      3        0                  3                    1   7

＊35) In the case with mixture type, the type having the most significant impact on the clinical symptom is listed. But, if the impacts are similar, multiple response is allowed. ＊36) Including cervical rib.

###### Table 8-4 Vascular access operation

  Treatment                                                     Cases    30-day mortality
  ------------------------------------------------------------- -------- ------------------
  Arteriovenous access creation by autogenous material          11,753   138
  Arteriovenous access creation by artificial material\*^37)^   2,651    48
  Open surgery for access repair                                2,449    45
  Endovascular access repair                                    5,426    48
  Arterial transposition                                        375      16
  Total                                                         22,654   295

＊37) Including cases with access repair using artificial graft.

###### Table 8-5 Surgery for lymphedema

  Treatment                  Cases   Male   Female   30-day mortality
  -------------------------- ------- ------ -------- ------------------
  Lymphovenous anastomosis   43      7      36       0
  Lymph drainage operation   5       2      3        0
  Resection                  56      32     24       1
  Total                      104     41     63       1

###### Table 8-6 Symphathectomy

  Symphathectomy           Cases   30-day mortality
  ------------------------ ------- ------------------
  Thoracic sympathectomy   30      1
  Lumbar sympathectomy     9       0
  Total                    39      1

###### Table 8-7 Amputation of upper limb

  Amputation level    Cases   30-day mortality
  ------------------- ------- ------------------
  Digit               18      0
  Forearm/upper arm   5       1
  Total               23      1

###### Table 8-8 Amputation of lower limb\*^38)^

  Amputation level          Cases   30-day mortality   Etiology              
  ------------------------- ------- ------------------ ---------- ----- ---- ----
  Toe                       540     15                 207        289   6    38
  Transmetatarsal           202     7                  62         131   3    6
  Lisfranc/Chopart          63      4                  21         41    1    0
  Syme                      9       0                  4          5     0    0
  Below-knee                237     8                  105        117   1    14
  Through-knee/above-knee   337     33                 183        112   2    40
  Hip                       2       0                  1          0     0    1
  Total                     1,390   67                 583        695   13   99

＊38) Amputations not due to ischemia are not included. Abbreviations; ASO: arteriosclerosis obriterance, DM-ASO: diabetic ASO, TAO: thromboangiitis obliterans (Buerger's disease)

1) Popliteal artery entrapment syndrome and cystic adventitial disease
----------------------------------------------------------------------

The number of cases tended to increase as observed previously, possibly reflecting an improvement in the diagnostic rate.

2) Vascular access surgery (Table 8-4)
--------------------------------------

The number of surgeries performed increased by 39.0%, and all surgical procedures including those with and without synthetic grafts showed an even increase.

3) Lymphedema surgery (Table 8-5)
---------------------------------

The number of performed surgeries was small but increased slightly. Lymphovenous anastomosis was performed in 43 cases.

4) Sympathectomy (Table 8-6)
----------------------------

Sympathectomy was performed only in 39 cases, and we believe that this finding indicates the limited indication of this surgical procedure.

5) Amputation of the upper limb and lower limb (Tables 8-7 and 8-8)
-------------------------------------------------------------------

There was a 34.0% increase in lower limb amputation cases, and minor and major amputations showed increased number of cases. Transfemoral (above-knee) amputations remained more common compared with below-knee amputations, and the death rate related to transfemoral amputations was as high as 9.7%, similar to that observed in the previous year ([**Fig. 5**](#figure5){ref-type="fig"}). Below-knee amputation due to ischemia is often performed in orthopedic or plastic surgery departments, and the numbers in this report only reflect a portion of the amputations performed in Japan. Data collection across specialities will be required at the earliest possible opportunity to understand the overall condition of major amputations performed in Japan. This will lead to improved limb salvage rates and will be the first step in improving the high death rate associated with amputation.

![Fig. 5 The number of lower limb amputations and their mortality rates in each amputation level. The value on the top of each bar indicates the 30-day mortality rate. The mortality rate after amputation surgery became signiﬁcantly higher in according to higher amputation level (p\<0.001).](avd-12-2-ar.19-00030-figure05){#figure5}

Conclusions
===========

Since the NCD registration began in 2011, an overall representation of vascular surgery in 2012 has been established. Although these results show simple statistics, observation of the current state of vascular surgery in Japan is possible, along with the understanding of gradual changes in the contents of vascular surgery.

One of the largest goals of establishing the NCD is to improve the quality of medicine using NCD data. In this aspect, there are several tasks requiring future investigation, with the first task being entry criteria. The current criteria are determined based on attributes used in vascular surgery questionnaires established prior to the establishment of the NCD. However, they are insufficient in evaluating the quality of current medical services. Considering that data are entered in the midst of busy clinical works, determining which items are essential for vascular registry is one of our next tasks. The other task is to determine an indicator for vascular treatment quality. The operative mortality rate is fortunately low in most vascular surgeries other than major vascular surgery; hence, it cannot be used as an indicator. Therefore, the aim is to implement a function in the NCD to compare the risk adjusted quality indicator of vascular treatment in each institution with national standards. JSVS has initiated several model studies to tackle these future tasks. Additionally, site visits will be introduced in this fiscal year to improve data reliability.

We hope to further develop the vascular surgery database of the NCD with the help of JSVS members. We sincerely hope that this database will assist in providing high-quality medical service to patients suffering from vascular diseases.
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